MapLight Therapeutics, Inc. Common Stock Long-term Investment Intensity
MapLight Therapeutics, Inc. Common Stock long-term investment intensity. MapLight Therapeutics, Inc. Common Stock (MPLT) has a Long-term Investment Intensity of 12.7% as of June 2026. Long-term investments of $46.62 Million represent 12.7% of total assets of $368.35 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read how much debt does MapLight Therapeutics, Inc. Common Stock carry for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of MapLight Therapeutics, Inc. Common Stock (2025–2025)
Long-term investment intensity of MapLight Therapeutics, Inc. Common Stock from 2025 to 2025. This chart shows how MapLight Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of June 2026, the intensity stands at 12.7%, reflecting long-term investments of $46.62 Million against total assets of $368.35 Million USD.
MapLight Therapeutics, Inc. Common Stock Long-term Investment Intensity by Year (2025–2025)
MapLight Therapeutics, Inc. Common Stock long-term investment intensity by year from 2025 to 2025. The table below presents the year-by-year Long-term Investment Intensity for MapLight Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of MapLight Therapeutics, Inc. Common Stock.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 30.9% | $147.99 Million | $479.51 Million | — |